(Q46942430)
Statements
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer (English)
R Rosell
G Robinet
A Szczesna
M Constenla
B C Mennecier
W Pfeifer
K J O'Byrne
T Welte
R Kolb
R Pirker
A Chemaissani
M Perol
M R Ranson
P A Ellis
K Pilz